jan hein cornel
jan hein cornel
Cardiologist, Northwest Clinics, Alkmaar , Radboudumc, Nijmegen, The Netherlands
Adresse e-mail validée de quicknet.nl
Citée par
Citée par
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
Rosuvastatin in older patients with systolic heart failure
J Kjekshus, E Apetrei, V Barrios, M Böhm, JGF Cleland, JH Cornel, ...
New England Journal of Medicine 357 (22), 2248-2261, 2007
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study
Capture Investigators
Lancet 349, 1429-1435, 1997
Apixaban with antiplatelet therapy after acute coronary syndrome
JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ...
New England Journal of Medicine 365 (8), 699-708, 2011
Lenient versus strict rate control in patients with atrial fibrillation
IC Van Gelder, HF Groenveld, HJGM Crijns, YS Tuininga, JGP Tijssen, ...
New England Journal of Medicine 362 (15), 1363-1373, 2010
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure
HL Hillege, D Nitsch, MA Pfeffer, K Swedberg, JJV McMurray, S Yusuf, ...
Circulation 113 (5), 671-678, 2006
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ...
New England Journal of Medicine 367 (14), 1297-1309, 2012
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ...
New England Journal of Medicine 366 (1), 20-33, 2012
Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary …
JJ Bax, W Wijns, JH Cornel, FC Visser, E Boersma, PM Fioretti
Journal of the American College of Cardiology 30 (6), 1451-1460, 1997
Early invasive versus selectively invasive management for acute coronary syndromes
RJ de Winter, F Windhausen, JH Cornel, PHJM Dunselman, CL Janus, ...
New England Journal of Medicine 353 (11), 1095-1104, 2005
Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial
SJ Nicholls, R Puri, T Anderson, CM Ballantyne, L Cho, JJP Kastelein, ...
Jama 316 (22), 2373-2384, 2016
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low-dose dobutamine echocardiography with 201Tl single-photon …
M Arnese, JH Cornel, A Salustri, APWM Maat, A Elhendy, AEM Reijs, ...
Circulation 91 (11), 2748-2752, 1995
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable …
JJ Bax, D Poldermans, A Elhendy, JH Cornel, E Boersma, R Rambaldi, ...
Journal of the American College of Cardiology 34 (1), 163-169, 1999
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
S James, DJ Angiolillo, JH Cornel, D Erlinge, S Husted, F Kontny, J Maya, ...
European heart journal 31 (24), 3006-3016, 2010
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino Sr, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
S James, A Budaj, P Aylward, KK Buck, CP Cannon, JH Cornel, ...
Circulation 122 (11), 1056-1067, 2010
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled …
PM Ridker, JG MacFadyen, BM Everett, P Libby, T Thuren, RJ Glynn, ...
The Lancet 391 (10118), 319-328, 2018
Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.
WJ McKenna, P Spirito, M Desnos, O Dubourg, M Komajda
Heart 77 (2), 130-132, 1997
Impaired glucose metabolism predicts mortality after a myocardial infarction
J Bolk, TJ Van der Ploeg, JH Cornel, AER Arnold, J Sepers, V Umans
International journal of cardiology 79 (2-3), 207-214, 2001
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20